P085 | ASXL1 MUTATIONS DETERMINE INFERIOR OUTCOME IN LOWER-RISK MYELODYSPLASTIC SYNDROMES:MONOCENTRIC REAL-LIFE DATA
The management of lower-risk myelodysplastic syndromes (LR-MDS), defined by IPSS-R as very low,low and intermediate-risk categories, is focused on the treatment of cytopenias, with the aim of improving quality of life and risk of disease progression. IPSS-molecular (M) has shown to provide better r...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Ferrata Storti Foundation
2025-09-01
|
| Series: | Haematologica |
| Acceso en liña: | https://haematologica.org/article/view/12482 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|